View Older Stories View More Recent Stories

Oct 20, 2025 07:37AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT) After Management Meet
Oct 20, 2025 06:48AM Summit Therapeutics (SMMT) Tops Q3 EPS by 4c
Oct 20, 2025 06:45AM Summit Therapeutics plans to submit BLA for cancer drug in Q4 2025
Oct 17, 2025 07:00AM Summit Therapeutics launches phase III colorectal cancer trial
Oct 10, 2025 09:29AM UBS Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Oct 4, 2025 04:00PM Why UBS says Q4 is eventful for SMID oncology stocks
Sep 25, 2025 04:14AM Citi Opens 30-Day Upside Catalyst Watch on Summit Therapeutics plc (SMMT)
Sep 24, 2025 07:00AM Summit presents lung cancer trial data at ESMO 2025
Sep 17, 2025 04:36AM Barclays Starts Summit Therapeutics plc (SMMT) at Underweight
Sep 16, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Sep 10, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Sep 9, 2025 05:28AM Summit Therapeutics (SMMT) call put ratio 1.9 calls to 1 put amid wide price movement
Sep 8, 2025 07:36AM Akeso reports improved survival data for cancer drug ivonescimab
Sep 8, 2025 07:12AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Sep 8, 2025 04:20AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Sep 3, 2025 04:13PM Guggenheim Starts Summit Therapeutics plc (SMMT) at Buy
Sep 3, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Aug 27, 2025 06:36AM Summit Therapeutics plc (SMMT) PT Raised to $50 at H.C. Wainwright, 'Time to own SMMT'
Aug 26, 2025 11:48AM TD Cowen on Summit Therapeutics plc (SMMT): 'Stat Sig Overall Survival In Akeso's HARMONi-A Bodes Well For Summit's HARMONi'
Aug 22, 2025 07:48AM UBS Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Aug 19, 2025 06:18AM Piper Sandler Starts Summit Therapeutics plc (SMMT) at Neutral
Aug 19, 2025 04:29AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Aug 12, 2025 05:13AM Summit Therapeutics plc (SMMT) PT Raised to $34 at Evercore ISI
Aug 12, 2025 03:34AM Summit Therapeutics (SMMT) Misses Q2 EPS by 3c
Jul 28, 2025 07:20AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
Jul 3, 2025 10:17AM Summit Therapeutics (SMMT) Is Said In Talks For $15 Billion Partnership With Astra (AZN) - Bloomberg
Jul 1, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Jul 1, 2025 12:49AM UBS Starts Summit Therapeutics plc (SMMT) at Buy
Jun 30, 2025 12:54PM Clear Street Starts Summit Therapeutics plc (SMMT) at Buy
Jun 30, 2025 08:07AM Revolution Medicines (RVMD) and Summit Therapeutics (SMMT) Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors
Jun 24, 2025 06:35AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
Jun 11, 2025 06:19AM Leerink Partners Starts Summit Therapeutics plc (SMMT) at Underperform
Jun 2, 2025 06:46AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
Jun 2, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Jun 2, 2025 04:07AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
May 30, 2025 07:54AM Summit Therapeutics (SMMT): Ivonescimab Plus Chemo Demonstrates Statistically Significant and Clinically Meaningful Improvement in PFS in Patients with EGFR-Mutant NSCLC
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 28, 2025 04:25AM Citizens JMP shares updates on cancer treatment stocks
May 22, 2025 12:33AM Clear Street Starts Summit Therapeutics plc (SMMT) at Buy
May 8, 2025 05:29AM TD Cowen Upgrades Summit Therapeutics plc (SMMT) to Buy
May 2, 2025 10:18AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
May 1, 2025 04:10PM Summit Therapeutics (SMMT) Tops Q1 EPS by 2c
Apr 28, 2025 07:36AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Apr 28, 2025 05:49AM Summit Therapeutics (SMMT) options active on volume of 49K contracts
Apr 28, 2025 05:35AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Apr 25, 2025 03:00PM Summit Therapeutics (SMMT) to Resume Trading at 3:30 p.m.
Apr 25, 2025 02:52PM Summit Therapeutics (SMMT): Interim OS Analysis Requested from Chinese Health Authorities Shows Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive A
Apr 25, 2025 12:35PM Summit Therapeutics (SMMT) Halted, News Pending
Apr 25, 2025 11:55AM Summit Therapeutics (SMMT) Halted on Volatility, Down 34%
Apr 25, 2025 11:46AM BioNTech SE (BNTX) Hits Low, Down 8%, Summit Therapeutics (SMMT) Falls 18.5%
View More Recent Stories View Older Stories